1. Massive underreporting of adverse drug reactions continues

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Be on the alert for drug-induced benign intracranial hypertension

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Medication errors observed in 50% of discharged patients

   Newsletter Article 31 January 2013 Pages: 2 - 2

4. Call for long term study on the hypothesis that thyroxine effects on the bone can be minimised

   Newsletter Article 31 January 2013 Pages: 2 - 3

5. Assessment of drug-induced peripheral neuropathy

   Newsletter Article 31 January 2013 Pages: 3 - 4

6. Alprazolam interaction

   Newsletter Article 31 January 2013 Pages: 4 - 4

7. Amitriptyline

   Newsletter Article 31 January 2013 Pages: 4 - 4

8. Antineoplastics

   Newsletter Article 31 January 2013 Pages: 4 - 4

9. Antipsychotics

   Newsletter Article 31 January 2013 Pages: 4 - 5

10. Aztreonam

    Newsletter Article 31 January 2013 Pages: 5 - 5

11. Beta blockers see Contrast media interaction

    Newsletter Article 31 January 2013 Pages: 5 - 5

12. Bleomycin

    Newsletter Article 31 January 2013 Pages: 5 - 5

13. Bucillamine

    Newsletter Article 31 January 2013 Pages: 5 - 5

14. Bupivacaine

    Newsletter Article 31 January 2013 Pages: 5 - 5

15. Cefazolin

    Newsletter Article 31 January 2013 Pages: 5 - 5

16. Cocaine abuse

    Newsletter Article 31 January 2013 Pages: 5 - 5

17. Contrast media interaction

    Newsletter Article 31 January 2013 Pages: 5 - 6

18. Cyclosporin

    Newsletter Article 31 January 2013 Pages: 6 - 6

19. Cyclosporin overdose

    Newsletter Article 31 January 2013 Pages: 6 - 6

20. Cyproterone/ethinylestradiol

    Newsletter Article 31 January 2013 Pages: 6 - 6

21. Cytarabine

    Newsletter Article 31 January 2013 Pages: 6 - 6

22. Dapsone

    Newsletter Article 31 January 2013 Pages: 6 - 6

23. Diazepam

    Newsletter Article 31 January 2013 Pages: 6 - 7

24. Dideoxyinosine

    Newsletter Article 31 January 2013 Pages: 7 - 7

25. Diltiazem

    Newsletter Article 31 January 2013 Pages: 7 - 7

26. Diltiazem overdose

    Newsletter Article 31 January 2013 Pages: 7 - 7

27. Dinoprostone

    Newsletter Article 31 January 2013 Pages: 7 - 7

28. Enalapril

    Newsletter Article 31 January 2013 Pages: 7 - 7

29. Ergotamine

    Newsletter Article 31 January 2013 Pages: 7 - 7

30. Ethinylestradiol see Cyproterone/ethinylestradiol

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Fentanyl/halothane/vecuronium bromide

    Newsletter Article 31 January 2013 Pages: 8 - 8

32. Fludarabine

    Newsletter Article 31 January 2013 Pages: 8 - 8

33. Fluorouracil

    Newsletter Article 31 January 2013 Pages: 8 - 8

34. Fluoxetine

    Newsletter Article 31 January 2013 Pages: 8 - 8

35. Flurbiprofen/indomethacin

    Newsletter Article 31 January 2013 Pages: 8 - 8

36. Foscarnet

    Newsletter Article 31 January 2013 Pages: 8 - 8

37. Gold

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Halothane

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Halothane see Fentanyl/halothane/vecuronium bromide

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Imipramine see Alprazolam interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Indomethacin see Flurbiprofen/indomethacin

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Lindane overdose

    Newsletter Article 31 January 2013 Pages: 8 - 9

43. Lisinopril

    Newsletter Article 31 January 2013 Pages: 9 - 9

44. Lithium

    Newsletter Article 31 January 2013 Pages: 9 - 9

45. Lorazepam

    Newsletter Article 31 January 2013 Pages: 9 - 9

46. Lovastatin

    Newsletter Article 31 January 2013 Pages: 9 - 9

47. Methotrexate

    Newsletter Article 31 January 2013 Pages: 9 - 9

48. Methylprednisolone see Triamcinolone/methylprednisolone

    Newsletter Article 31 January 2013 Pages: 9 - 9

49. Metoclopramide withdrawal

    Newsletter Article 31 January 2013 Pages: 9 - 10

50. Mianserin

    Newsletter Article 31 January 2013 Pages: 10 - 10